KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
AMS:PHIA - Euronext Amsterdam - NL0000009538 - Common Stock - Currency: EUR
PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 55 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
In the past year PHIA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -2.42%, PHIA perfoms like the industry average, outperforming 41.82% of the companies in the same industry.
PHIA has a Return On Equity (-5.85%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROIC | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Operating Margin of PHIA has declined.
PHIA has a Gross Margin of 43.13%. This is in the lower half of the industry: PHIA underperforms 69.09% of its industry peers.
PHIA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% |
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PHIA has less shares outstanding
The number of shares outstanding for PHIA has been increased compared to 5 years ago.
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.71, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PHIA (1.71) is comparable to the rest of the industry.
PHIA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as PHIA would need 8.68 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.68, PHIA is in line with its industry, outperforming 56.36% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.59. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.59 is on the low side compared to the rest of the industry. PHIA is outperformed by 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Altman-Z | 1.71 |
ROIC/WACCN/A
WACC6.25%
2.3 Liquidity
PHIA has a Current Ratio of 1.23. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
PHIA has a Current ratio of 1.23. This is in the lower half of the industry: PHIA underperforms 63.64% of its industry peers.
PHIA has a Quick Ratio of 1.23. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a worse Quick ratio (0.84) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.37% over the past year.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.07% yearly.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -0.82% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)12.37%
EPS 3Y-5.48%
EPS 5Y-7.07%
EPS Q2Q%26.36%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%1.98%
3.2 Future
PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.81% yearly.
The Revenue is expected to grow by 5.73% on average over the next years.
EPS Next Y11.88%
EPS Next 2Y13.66%
EPS Next 3Y13.18%
EPS Next 5Y15.81%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y5.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 18.17 indicates a rather expensive valuation of PHIA.
80.00% of the companies in the same industry are more expensive than PHIA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 29.35, PHIA is valued a bit cheaper.
The Price/Forward Earnings ratio is 16.20, which indicates a correct valuation of PHIA.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than 70.91% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. PHIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.17 | ||
| Fwd PE | 16.2 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as PHIA.
80.00% of the companies in the same industry are more expensive than PHIA, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.98 | ||
| EV/EBITDA | 20.98 |
4.3 Compensation for Growth
PHIA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHIA's earnings are expected to grow with 13.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.53
PEG (5Y)N/A
EPS Next 2Y13.66%
EPS Next 3Y13.18%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (3/7/2025, 7:00:00 PM)
25.26
+0.01 (+0.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners48.26%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.74B
Analysts73.33
Price Target29.01 (14.85%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP-0.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.57%
Min EPS beat(2)-16.56%
Max EPS beat(2)-10.58%
EPS beat(4)0
Avg EPS beat(4)-11.81%
Min EPS beat(4)-16.56%
Max EPS beat(4)-6.96%
EPS beat(8)2
Avg EPS beat(8)0.96%
EPS beat(12)3
Avg EPS beat(12)3.42%
EPS beat(16)5
Avg EPS beat(16)1.26%
Revenue beat(2)0
Avg Revenue beat(2)-2.99%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)-0.76%
Revenue beat(4)0
Avg Revenue beat(4)-2.85%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-0.76%
Revenue beat(8)1
Avg Revenue beat(8)-2.36%
Revenue beat(12)2
Avg Revenue beat(12)-1.5%
Revenue beat(16)2
Avg Revenue beat(16)-2.3%
PT rev (1m)0.29%
PT rev (3m)0.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.32%
EPS NY rev (1m)0.81%
EPS NY rev (3m)-6.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)-1.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.17 | ||
| Fwd PE | 16.2 | ||
| P/S | 1.32 | ||
| P/FCF | 26.98 | ||
| P/OCF | 15.26 | ||
| P/B | 1.98 | ||
| P/tB | N/A | ||
| EV/EBITDA | 20.98 |
EPS(TTM)1.39
EY5.5%
EPS(NY)1.56
Fwd EY6.17%
FCF(TTM)0.94
FCFY3.71%
OCF(TTM)1.66
OCFY6.55%
SpS19.17
BVpS12.77
TBVpS-1.45
PEG (NY)1.53
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.42% | ||
| ROE | -5.85% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.13% | ||
| FCFM | 4.88% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.25%
OM growth 5Y-8.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 8.68 | ||
| Debt/EBITDA | 5.15 | ||
| Cap/Depr | 48.63% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 112.67% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.23 | ||
| Quick Ratio | 0.84 | ||
| Altman-Z | 1.71 |
F-Score6
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.37%
EPS 3Y-5.48%
EPS 5Y-7.07%
EPS Q2Q%26.36%
EPS Next Y11.88%
EPS Next 2Y13.66%
EPS Next 3Y13.18%
EPS Next 5Y15.81%
Revenue 1Y (TTM)-0.82%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%1.98%
Revenue Next Year3.9%
Revenue Next 2Y4.18%
Revenue Next 3Y4.38%
Revenue Next 5Y5.73%
EBIT growth 1Y91.51%
EBIT growth 3Y-0.63%
EBIT growth 5Y-7.54%
EBIT Next Year67.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%